I share your enthusiasm about the oncology potential for Cytodyn. The FDA process may need to be followed as we progress and so be it. But is it not possible to issue a press release on the current results to date? It may simply be an investigative trial (not double blinded, placebo, etc..) but with such amazing quantitative results, if made public, would jolt the stock price much higher and ease the pressure on dilution as we raise funds for the future. This divulging of data should not impact any future FDA approvals as they will require us, most likely, to go through a ton of trials anyway.

So, am I missing something?